NM_004046.6(ATP5F1A):c.834G>A (p.Thr278=) AND not provided

Germline classification:: Likely benign (2 submissions)
Last evaluated:: Jun 16, 2022
Review status:: 2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV001722627.13

Allele description [Variation Report for NM_004046.6(ATP5F1A):c.834G>A (p.Thr278=)]

NM_004046.6(ATP5F1A):c.834G>A (p.Thr278=)

Gene:

ATP5F1A:ATP synthase F1 subunit alpha [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

18q21.1

Genomic location:

Preferred name:

NM_004046.6(ATP5F1A):c.834G>A (p.Thr278=)

HGVS:

NC_000018.10:g.46087458C>T
NG_041769.2:g.26776G>A
NM_001001935.3:c.684G>A
NM_001001937.2:c.834G>A
NM_001257334.2:c.768G>A
NM_001257335.2:c.684G>A
NM_004046.6:c.834G>AMANE SELECT
NP_001001935.1:p.Thr228=
NP_001001937.1:p.Thr278=
NP_001001937.1:p.Thr278=
NP_001244263.1:p.Thr256=
NP_001244264.1:p.Thr228=
NP_004037.1:p.Thr278=
NC_000018.9:g.43667424C>T
NM_001001937.1:c.834G>A

Links:

dbSNP: rs763102405

NCBI 1000 Genomes Browser:

rs763102405

Molecular consequence:

NM_001001935.3:c.684G>A - synonymous variant - [Sequence Ontology: SO:0001819]
NM_001001937.2:c.834G>A - synonymous variant - [Sequence Ontology: SO:0001819]
NM_001257334.2:c.768G>A - synonymous variant - [Sequence Ontology: SO:0001819]
NM_001257335.2:c.684G>A - synonymous variant - [Sequence Ontology: SO:0001819]
NM_004046.6:c.834G>A - synonymous variant - [Sequence Ontology: SO:0001819]

Condition(s)

Synonyms:: none provided
Identifiers:: MedGen: C3661900

Recent activity

Clear Turn Off Turn On

DA027094 ASTRO2 Homo sapiens cDNA clone ASTRO2010492 5', mRNA sequence
DA027094 ASTRO2 Homo sapiens cDNA clone ASTRO2010492 5', mRNA sequence
gi|79164026|gnl|dbEST|33042816|dbj| 094.1|

Nucleotide
Lactifluus brunneoviolascens voucher cofc-1526 internal transcribed spacer 1, pa...
Lactifluus brunneoviolascens voucher cofc-1526 internal transcribed spacer 1, partial sequence; 5.8S ribosomal RNA gene, complete sequence; and internal transcribed spacer 2, partial sequence
gi|2783424505|gb|PQ136478.1|

Nucleotide
Australian Chlamydia Treatment Study (ACTS)
Australian Chlamydia Treatment Study (ACTS)
A cohort study of azithromycin treatment failure in women with Chlamydia infections.

BioProject
Chain AX, 60S ribosomal protein L17-A
Chain AX, 60S ribosomal protein L17-A
gi|2463611609|pdb|8BQX|AX

Protein

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV000716808	GeneDx	criteria provided, single submitter (GeneDx Variant Classification Process June 2021)	Likely benign (Dec 24, 2020)	germline	clinical testing	Citation Link,
SCV003488675	Labcorp Genetics (formerly Invitae), Labcorp	criteria provided, single submitter (Invitae Variant Classification Sherloc (09022015))	Likely benign (Jun 16, 2022)	germline	clinical testing	PubMed (1) [See all records that cite this PMID]

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV000716808

GeneDx

criteria provided, single submitter

(GeneDx Variant Classification Process June 2021)

Likely benign
(Dec 24, 2020)

germline

clinical testing

Citation Link,

SCV003488675

Labcorp Genetics (formerly Invitae), Labcorp

criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))

Likely benign
(Jun 16, 2022)

germline

clinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	yes	not provided	not provided	not provided	not provided	not provided	clinical testing
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]

PMID:: 28492532
PMCID:: PMC5632818

Details of each submission

From GeneDx, SCV000716808.3

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	not provided

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	yes	not provided	not provided	not provided		not provided	not provided	not provided	not provided

From Labcorp Genetics (formerly Invitae), Labcorp, SCV003488675.2

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	PubMed (1)

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Nov 10, 2024

ClinVar

Relating variation to medicine